Combination of Ruxolitinib and Magrolimab Significantly Increases Calreticulin Expression in Myelofibrosis CD34+ Cells in Vitro. Proof of Concept for Combination Therapy

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 12165 - 12166
Main Authors Boasman, Kristian, Simmonds, Matthew J, Rinaldi, Ciro R
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-163769